Back
Corporate News
Morepen Laboratories subsidiary Morepen RX allotted shares totaling Rs 20 crore through a rights issue
06-Aug-2026, 05:54
Morepen Laboratories Limited announced that its wholly owned subsidiary, Morepen RX Limited (MRX), has allotted 20,00,00,000 equity shares with a face value of Rs 10 each, totaling Rs 20,00,00,000, to the company through a rights issue. Consequently, Morepen Laboratories Limited’s shareholding in MRX has increased to 2,70,82,356 equity shares, and MRX continues to be a wholly owned subsidiary. MRX, incorporated on March 17, 2023, had a turnover of Rs 5,449.84 lakh and a net worth of Rs 47.72 lakh based on audited financial statements for the financial year ended March 31, 2026.
Morepen Laboratories Limited announced that its wholly owned subsidiary, Morepen RX Limited (MRX), has allotted 20,00,00,000 equity shares with a face value of Rs 10 each, totaling Rs 20,00,00,000, to the company through a rights issue. Consequently, Morepen Laboratories Limited’s shareholding in MRX has increased to 2,70,82,356 equity shares, and MRX continues to be a wholly owned subsidiary. MRX, incorporated on March 17, 2023, had a turnover of Rs 5,449.84 lakh and a net worth of Rs 47.72 lakh based on audited financial statements for the financial year ended March 31, 2026.